```

[Federal Register Volume 89, Number 232 (Tuesday, December 3, 2024)]
[Notices]
[Pages 95795-95797]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28321]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-25-25BN; Docket No. CDC-2024-0098]

Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a proposed information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled 2024 Marburg Traveler Symptom Monitoring and Feedback. This 
information collection is designed to conduct post-arrival symptom 
monitoring of travelers who have been in the outbreak area and evaluate 
the impact of rerouting and public health entry screening on travelers.

DATES: CDC must receive written comments on or before February 3, 2025.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0098 by either of the following methods:

[[Page 95796]]

     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov. Please note: Submit all comments through the 
Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the 
address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    2024 Marburg Traveler Symptom Monitoring and Feedback--New--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC), National 
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division 
of Global Migration Health (DGMH) requests an Emergency approval for a 
New information collection. Section 361 of the Public Health Service 
(PHS) Act (42 U.S.C. 264) authorizes the Secretary of Health and Human 
Services to make and enforce regulations necessary to prevent the 
introduction, transmission or spread of communicable diseases from 
foreign countries into the United States. Under its delegated 
authority, DGMH works to fulfill this responsibility through a variety 
of activities, including the operation of Port Health Stations at ports 
of entry and administration of foreign quarantine regulations; 42 Code 
of Federal Regulation part 71 (specifically 42 CFR 71.20), public 
health prevention measures to detect communicable disease. This 
information collection concerns CDC's responsibility to ensure the 
successful implementation of traveler monitoring to prevent the 
transmission or spread of communicable diseases into the United States.
    On February 21, 2020, CDC issued an interim final rule (IFR) to 
amend its Foreign Quarantine regulations, to enable CDC to require 
airlines to collect, and provide to CDC, certain data regarding 
passengers and crew arriving from foreign countries for the purposes of 
health education, treatment, prophylaxis, or other appropriate public 
health interventions, including travel restrictions. CDC's authority 
for collecting data for travelers arriving in the United States is 
contained in 42 CFR 71. Under this IFR, airlines must transmit these 
data to CDC within 24 hours of an order. The order Requirement for 
Airlines and Operators to Collect and Transmit Designated Information 
for Passengers and Crew Arriving into the United States; Requirement 
for Passengers to Provide Designated Information requiring the 
collection of this information was issued on October 25, 2021 and went 
into effect on November 8, 2021. Under this order, airlines may 
transmit the required information using the existing data-sharing 
infrastructure in place between the United States Department of 
Homeland Security (DHS) and HHS/CDC or they must retain the information 
for a minimum of 30 days and transmit it to CDC within 24 hours upon 
request. This information collection for contact information is already 
approved under OMB Control No. 0920-1354.
    In September 2024, an outbreak of Marburg virus was detected in the 
Republic of Rwanda. DHS has instructed airlines to redirect flights 
carrying persons who have recently traveled from or were otherwise 
present within Rwanda to land at designated U.S. airports. CDC is 
conducting public health entry screening at these designated U.S. 
airports of travelers coming from Rwanda. The purpose of public health 
entry screening is to detect ill travelers or travelers arriving from 
regions affected by the outbreak who are at risk of becoming ill with 
Marburg to facilitate post-arrival management. This information 
collection has been approved under OMB Control Number 0920-1443.
    CDC will utilize information collected during public health entry 
screening (approved under OMB Control Number 0920-1443) to determine 
which travelers should be monitored for Marburg symptoms in accordance 
with CDC's interim recommendations for post-arrival public health 
management of travelers from Rwanda. Monitoring of travelers will be 
done via text message and web survey and will take place over a period 
of 21 days from the traveler's last documented Marburg exposure. Text 
messages and web survey will be available in English and with an 
additional translated Kinyarwanda version. The information collected 
will allow CDC to identify the level of follow up necessary based on 
the level of risk of exposure to Marburg and determine if additional 
risk assessment and/or targeted public health measures are needed. 
Information collected from travelers during symptom monitoring will be 
shared with state and local health departments through existing secure 
data-sharing infrastructure. This information collection is necessary 
to facilitate post-arrival public health management of travelers as 
specified in CDC interim recommendations for management of U.S.-based 
healthcare personnel who have been in Rwanda and interim 
recommendations for post-arrival public health management of travelers 
from Rwanda. At the end of the 21-day monitoring period, CDC will

[[Page 95797]]

send a final survey to travelers intended to evaluate the impact of 
rerouting and public health entry screening on travelers. The results 
of this final survey will allow CDC to identify the most efficient 
channels for reaching travelers and refine public health messaging for 
travelers coming from the outbreak area.
    CDC requests OMB approval for an estimated 2,833 annual burden 
hours. There is no cost to respondents other than their time to 
participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                      Number        Avg. burden
     Type of respondent           Form name          Number of     responses per   per response    Total burden
                                                    respondents     respondent       (in hrs.)       (in hrs.)
----------------------------------------------------------------------------------------------------------------
Traveler...................  2024 Marburg                    438              21            1/60             153
                              Symptom Monitoring
                              Daily Group.
                             2024 Marburg                    438              21            5/60             767
                              Symptom Monitoring
                              Daily Group--Web
                              Survey for
                              Symptomatic
                              Travelers.
Traveler...................  2024 Marburg                  3,942               3            1/60             197
                              Symptom Monitoring
                              Weekly Group.
                             2024 Marburg                  3,942               3            5/60             986
                              Symptom Monitoring
                              Weekly Group--Web
                              Survey for
                              Symptomatic
                              Travelers.
Traveler...................  2024 Marburg                  4,380               1           10/60             730
                              Response Survey of
                              Travelers.
                                                 ---------------------------------------------------------------
    Total..................  ...................  ..............  ..............  ..............           2,833
----------------------------------------------------------------------------------------------------------------

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-28321 Filed 12-2-24; 8:45 am]
BILLING CODE 4163-18-P
```